During the past decade, Peking University Insititute of Hematology, Peking University People's Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking University Insititute of Hematology, Peking University People's Hospital" #1 collaborator was "Beijing Hospital" with 5 trials as a collaborator, "Beijing Tongren Hospital" with 4 trials as a collaborator, "Navy General Hospital, Beijing" with 4 trials as a collaborator, "Qilu Hospital of Shandong University" with 3 trials as a collaborator and "Beijing Aerospace General Hospital" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Peking University Insititute of Hematology, Peking University People's Hospital" are "Immune Thrombocytopenia" (15 trials), "ITP" (3 trials), "Blood Coagulation Disorders" (1 trials), "Bruton Tyrosine Kinase" (1 trials) and "Graft Vs Host Disease" (1 trials). Many other conditions were trialed in "Peking University Insititute of Hematology, Peking University People's Hospital" in a lesser frequency.

Most popular intervention types in "Peking University Insititute of Hematology, Peking University People's Hospital" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Danazol" (4 trials), "Eltrombopag" (4 trials), "Acetylcysteine" (2 trials), "Dexamethasone" (2 trials) and "Zanubrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peking University Insititute of Hematology, Peking University People's Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Peking University Insititute of Hematology, Peking University People's Hospital". 4 are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Peking University Insititute of Hematology, Peking University People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peking University Insititute of Hematology, Peking University People's Hospital, 3 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".